Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Effects of AP0302 5% (S-Ibuprofen Topical Gel 5%) Versus the Vehicle Control on Delayed Onset Muscle Soreness of the Elbow Flexors

NCT02324985 is registered in ClinicalTrials.gov with Aponia Laboratories, Inc. as lead sponsor.

NCT NCT02324985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02324985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Effects of AP0302 5% (S-Ibuprofen Topical Gel 5%) Versus the Vehicle Control on Delayed Onset Muscle Soreness of the Elbow Flexors
Lead sponsor
Aponia Laboratories, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
June 30, 2016
Enrollment
147 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed onset muscle soreness, pain